A potential role for an mTORC2-cytoskeleton-mitochondrial positioning axis as a regulatory module underlying spatially confined oxidative injury is suggested and new insights into how subcellular organization shapes redox-dependent cell fate decisions are provided.
Abstract
Mitoxyperilysis is a recently defined lytic cell death modality characterized by plasma membrane rupture driven by spatially confined mitochondrial oxidative damage under immunometabolic co-stress. However, the upstream mechanisms governing its spatial organization remain poorly defined. Here, we propose a conceptual framework in which mechanistic target of rapamycin complex 2 (mTORC2) may act as a critical spatial regulator linking immunometabolic stress to localized redox injury. Sustained mTORC2 activation suppresses RhoA-dependent cytoskeletal dynamics and lamellipodium formation, thereby impairing membrane dynamics and promoting prolonged mitochondria-plasma membrane contact. This spatial confinement may facilitate localized accumulation of mitochondrial reactive oxygen species (ROS), which could promote lipid peroxidation and ultimately lead to plasma membrane destabilization and lytic cell death. We further compare mitoxyperilysis with other redox-associated cell death modalities, emphasizing its defining feature of spatially restricted oxidative membrane damage. In addition, we discuss its potential relevance in pathological contexts associated with chronic immunometabolic stress. Collectively, this review suggests a potential role for an mTORC2-cytoskeleton-mitochondrial positioning axis as a regulatory module underlying spatially confined oxidative injury and provides new insights into how subcellular organization shapes redox-dependent cell fate decisions. This framework may inform the development of spatially targeted therapeutic strategies in immunometabolic diseases.
Clear cell renal cell carcinoma (ccRCC) is characterized by profound metabolic dysregulation, with both prolyl hydroxylase domain protein 3 (PHD3) and pyruvate carboxylase (PC) independently implicated in disease progression. Although each influences patient outcomes, a direct mechanistic interplay between these two re...
Jaelim Sim, Soyeon Lim, Chang-Jun Lee et al.· Experimental and Molecular M...· 0 citations
Understanding mitochondrial microautophagy may reveal new therapeutic opportunities for mitochondrial dysfunction-associated disorders, including neurodegeneration, ischemic injury, metabolic disorders, and aging.
Hui-Jiao Zhang, Ying Chen, Jun-Jie Jiang et al.· Antioxidants and Redox Signa...· 0 citations
DJ-1 is a redox-sensitive protein implicated in early-onset Parkinson’s disease, and its mitochondrial localization protects against oxidative stress, but the mechanisms regulating its submitochondrial targeting and functional impact on mitochondrial integrity remain poorly understood. We identify voltage-dependent ani...
Jéssica Taday, D. Im, S. Hewitt et al.· bioRxiv· 0 citations
Membrane contact sites (MCSs) are specialized, non-fusogenic interfaces that allow organelles to exchange ions, lipids, metabolites and stress signals. These contacts support adaptation to nutrient, proteotoxic and inflammatory stress. However, persistent or misregulated organelle communication can redirect metabol...
Ya-Qin Hou, Da-Chen Luo, Jia-Le Chen et al.· Cell Communication and Signa...· 0 citations
Type 2 diabetes mellitus (T2DM)-associated sarcopenia is driven by protein degradation and impaired myogenic regeneration. While classical models emphasize cytosolic kinase pathways, the subcellular mechanisms mediating lipotoxicity-induced chronic catabolism remain incompletely understood. This review elucidates a t...
Ling-Feng Wu, Ye Wang, Kai-Lian Ma et al.· Frontiers in Endocrinology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.